TY - JOUR
T1 - Quality Indicators in Palliative Radiation Oncology
T2 - Development and Pilot Testing
AU - Saito, Tetsuo
AU - Shikama, Naoto
AU - Takahashi, Takeo
AU - Miwa, Misako
AU - Miyazawa, Kazunari
AU - Wada, Hitoshi
AU - Nakamura, Naoki
AU - Yorozu, Atsunori
AU - Nagakura, Hisayasu
AU - Miyashita, Mitsunori
N1 - Funding Information:
Sources of support: This study was supported by the Health Labor Sciences Research Grant from the Ministry of Health, Labor, and Welfare of Japan (19EA1010).
Publisher Copyright:
© 2021 The Author(s)
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Purpose: A quality indicator (QI) is a valuable tool to evaluate the quality of health care systems. In palliative radiation oncology, only a few related QIs have been developed to date. In this study, we sought to develop and pilot test QIs that assess the quality of care in palliative radiation therapy. Methods and Materials: A modified Delphi method was used to establish consensus with an expert panel. The panel consisted of 8 radiation oncologists who have expertise in palliative radiation oncology and 1 expert on Delphi methodology. Online panel meetings and e-mail surveys were conducted to develop QIs on palliative radiation therapy for bone and brain metastases. Feasibility of measurement was assessed though pilot surveys that were conducted by radiation oncologists at 5 facilities. Results: After 3 online meetings and 2 e-mail surveys, we developed 4 QIs on bone metastases and 3 QIs on brain metastases. Two email surveys and 2 pilot surveys confirmed the validity of QIs and the feasibility of measurement, respectively. Conclusions: We developed valid and feasible QIs on palliative radiation therapy for bone and brain metastases. Our work may contribute to reduce the evidence–practice gaps in palliative radiation oncology.
AB - Purpose: A quality indicator (QI) is a valuable tool to evaluate the quality of health care systems. In palliative radiation oncology, only a few related QIs have been developed to date. In this study, we sought to develop and pilot test QIs that assess the quality of care in palliative radiation therapy. Methods and Materials: A modified Delphi method was used to establish consensus with an expert panel. The panel consisted of 8 radiation oncologists who have expertise in palliative radiation oncology and 1 expert on Delphi methodology. Online panel meetings and e-mail surveys were conducted to develop QIs on palliative radiation therapy for bone and brain metastases. Feasibility of measurement was assessed though pilot surveys that were conducted by radiation oncologists at 5 facilities. Results: After 3 online meetings and 2 e-mail surveys, we developed 4 QIs on bone metastases and 3 QIs on brain metastases. Two email surveys and 2 pilot surveys confirmed the validity of QIs and the feasibility of measurement, respectively. Conclusions: We developed valid and feasible QIs on palliative radiation therapy for bone and brain metastases. Our work may contribute to reduce the evidence–practice gaps in palliative radiation oncology.
UR - http://www.scopus.com/inward/record.url?scp=85123872833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123872833&partnerID=8YFLogxK
U2 - 10.1016/j.adro.2021.100856
DO - 10.1016/j.adro.2021.100856
M3 - Article
AN - SCOPUS:85123872833
SN - 2452-1094
VL - 7
JO - Advances in Radiation Oncology
JF - Advances in Radiation Oncology
IS - 2
M1 - 100856
ER -